MGNX · Macrogenics Inc · Executive Compensation

$4.00 +0.03 (+0.76%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$254.80M

63.70M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Risser	President, Chief Executive Officer and Director	$561,568	$150,000	$52,000	$1,049,386	$251,900	$14,000	$2,078,854
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$533,200	$150,000	$54,600	$288,038	$184,200	$14,000	$1,224,038
James Karrels	Senior Vice President and Chief Financial Officer	$506,548	$150,000	$49,400	$254,284	$175,000	$14,000	$1,149,232
Scott Koenig	M.D., Ph.D. Former Chief Executive Officer and current Director	$477,120	—	—	—	—	$475,841	$952,961

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	M.D., Ph.D. President, Chief Executive Officer and Director	$734,031	—	$1,738,500	$3,574,647	$342,470	$13,800	$6,403,448
Stephen Eck	M.D., Ph.D. Senior Vice President, Clinical Development and Chief Medical Officer	$542,769	—	$613,050	$1,297,251	$178,739	$13,800	$2,645,609
James Karrels	Senior Vice President, Chief Financial Officer and Corporate Secretary	$491,077	—	$549,000	$1,153,112	$158,554	$13,800	$2,365,543

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	M.D., Ph.D. President, Chief Executive Officer and Director	$704,914	—	$612,140	$1,894,191	$481,380	$13,200	$3,705,825
Stephen Eck	M.D., Ph.D. Senior Vice President, Clinical Development and Chief Medical Officer	$521,808	—	$241,000	$742,820	$231,840	$13,200	$1,750,668
James Karrels	Senior Vice President, Chief Financial Officer and Corporate Secretary	$471,106	—	$216,900	$668,538	$209,000	$13,200	$1,578,744

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	M.D., Ph.D. President, Chief Executive Officer and Director	$673,420	—	—	$3,568,656	$373,672	$12,200	$4,627,948
Eric Risser	Chief Operating Officer	$460,802	—	—	$1,263,899	$178,360	$12,200	$1,915,261
James Karrels	Senior Vice President, Chief Financial Officer and Corporate Secretary	$447,346	—	—	$1,040,858	$167,283	$12,200	$1,667,687

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	M.D., Ph.D. President, Chief Executive Officer and Director	$651,119	—	—	$3,914,372	$294,323	$8,700	$4,868,514
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$462,328	—	—	$1,677,588	$141,180	$8,700	$2,289,796
James Karrels	Senior Vice President, Chief Financial Officer and Corporate Secretary	$431,908	—	—	$1,328,091	$137,295	$8,700	$1,905,994
Eric Risser	Chief Operating Officer	$427,957	—	—	$1,328,091	$135,327	$8,700	$1,900,075
Thomas Spitznagel	Senior Vice President, Technical Operations	$409,972	—	—	$1,328,091	$132,302	$8,700	$1,879,065

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Eck	Senior Vice President, Clinical Development and Chief Medical Officer	$236,308	—	—	$4,788,880	$97,920	$7,089	$5,130,197
Scott Koenig	M.D., Ph.D. President, Chief Executive Officer and Director	$655,865	—	—	$2,065,873	$381,000	$8,550	$3,111,288
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$465,699	—	$249,700	$712,370	$183,960	$8,550	$1,620,279
James Karrels	Senior Vice President, Chief Financial Officer and Corporate Secretary	$431,496	—	—	$641,133	$173,791	$8,550	$1,254,970
Eric Risser	Chief Operating Officer	$431,077	—	—	$641,133	$170,284	$8,550	$1,251,044

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	M.D., Ph.D. President, Chief Executive Officer and Director	$590,019	—	—	$3,818,152	$307,017	$8,400	$4,723,588
Jon Wigginton	Senior Vice President, Clinical Development and Chief Medical Officer	$453,454	—	—	$1,321,668	$163,366	$3,763	$1,942,251
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$418,952	—	—	$1,321,668	$147,784	$8,400	$1,896,804
James Karrels	Senior Vice President, Chief Financial Officer and Corporate Secretary	$387,600	—	—	$1,248,242	$137,255	$8,400	$1,781,497
Eric Risser	Chief Operating Officer	$387,806	—	—	$1,248,242	$135,177	$8,400	$1,779,625

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	M.D., Ph.D. President, Chief Executive Officer and Director	$598,500	—	—	$4,289,558	$309,425	$8,250	$5,205,733
Jon Wigginton	Senior Vice President, Clinical Development and Chief Medical Officer	$460,000	—	—	$1,334,529	$173,328	$8,250	$1,976,107
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$425,000	—	—	$1,334,529	$160,140	$8,250	$1,927,919
Eric Risser	Senior Vice President, Business Development and Portfolio Management and Chief Business Officer	$393,404	—	—	$1,334,529	$148,549	$8,250	$1,884,732
James Karrels	Senior Vice President, Chief Financial Officer and Corporate Secretary	$390,000	—	—	$1,334,529	$148,512	$8,250	$1,881,291

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Scott Koenig	M.D., Ph.D. President, Chief Executive Officer and Director	$554,346	—	—	$2,565,060	$350,624	$8,100	$3,478,130
Jon Wigginton	Senior Vice President, Clinical Development and Chief Medical Officer	$445,050	—	—	$865,708	$197,600	$8,100	$1,516,458
Ezio Bonvini	Senior Vice President, Research and Chief Scientific Officer	$404,685	—	—	$865,708	$179,700	$8,100	$1,458,193
Eric Risser	Senior Vice President, Business Development and Portfolio Management and Chief Business Officer	$374,670	—	—	$705,392	$176,800	$8,100	$1,264,962
James Karrels	Senior Vice President, Chief Financial Officer and Corporate Secretary	$360,000	—	—	$705,392	$160,700	$8,100	$1,234,192

Executive changes

Person	Role	Change	Effective	Filed
Karen Ferrante, M.D.	Board	Resigned	2026-09-01	2026-07-08
Eric Risser	Class I director	Appointed	2025-08-13	2025-08-13
Eric Risser	President and Chief Executive Officer	Appointed	2025-08-13	2025-08-13
Beth Smith	Vice President, Controller, Treasurer and Principal Accounting Officer	Appointed	2025-01-02	2024-11-21
Lynn Cilinski	Vice President, Controller, Treasurer and Principal Accounting Officer	Retired	2025-01-02	2024-11-21

Key facts CIK 1125345 CUSIP 556099109 13F (30d) 52 filings 52 filers Visit website Investor relations